Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Kamal K. Mubarak"'
Autor:
Jawaharlal M. Patel, Yanfei Qi, Michael J. Katovich, Jane Yellowlees Douglas, J Mocco, Deepmala Agarwal, Erin Bruce, Altin Gjymishka, Anandharajan Rathinasabapathy, Chastity Bradford, Yagna P. R. Jarajapu, Patrick Kearns, Aqeela Afzal, Katya Rigatto, Mohan K. Raizada, Dipankar Gupta, Joo Yun Jun, Joseph Francis, Vinayak Shenoy, Kamal K. Mubarak, Rodrigo A. Fraga-Silva, William R. Kennedy, Maria B. Grant, Arturo J. Cardounel, Anderson J. Ferreira
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 187:648-657
Rationale: Studies have demonstrated that angiotensin-converting enzyme 2 (ACE2) plays a protective role against lung diseases, including pulmonary hypertension (PH). Recently, an antitrypanosomal drug, diminazene aceturate (DIZE), was shown to exert
Autor:
Hanbo Hu, Hassan Alnuaimat, Defang Luo, Kamal K. Mubarak, Jeffrey K. Harrison, Jawaharlal M. Patel, Robin D. Carrie, Jianliang Zhang, Nadia L. Palma, Xiaoqiang Shen
Publikováno v:
American Journal of Physiology-Lung Cellular and Molecular Physiology. 303:L912-L922
Distal arterioles with limited smooth muscles help maintain the high blood flow and low pressure in the lung circulation. Chronic hypoxia induces lung distal vessel muscularization. However, the molecular events that trigger alveolar hypoxia-induced
Publikováno v:
Chest. 139:115-121
Background Pulmonary artery occlusion pressure (PAOP) is used to differentiate patients with pulmonary hypertension (PH) associated with left-sided heart disease from other etiologies. Technical errors in the measurement of PAOP are common and lead t
A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension
Autor:
Kamal K. Mubarak
Publikováno v:
Respiratory Medicine. 104(1):9-21
SummaryPulmonary arterial hypertension is a chronic, progressive disease characterized by elevation of pulmonary artery pressure and pulmonary vascular resistance that ultimately results in right ventricular failure and death. Multiple mechanisms are
Autor:
Virginia D. Steen, Naomi F. Rothfield, Ed Parsley, Carla Maynetto, Sarinnapha Vasunilashorn, Jeffrey Golden, Edrick Forbes, Xiaohong Yan, Mildred Sterz, Jonathan G. Goldin, Donald P. Tashkin, David J. Riley, Marcie Bolster, Arthur C. Theodore, Deborah A. McCloskey, Irene Da Costa, Anise Carey, Fran Ingenito, Macha Aberles, Barbara White, Michael F. Bonner, Joanie Chung, Robert D. Suh, Sean Wheaton, Ken Bulpitt, James R. Seibold, Daniel Furst, José L. Granda, Marcy B. Bolster, Philip J. Clements, Adriana Ortiz, Mark Bohlman, June Arnold, Kimberley Tobin, Elena Breen, Robert E. Elashoff, Colleen Sanders, Sherrie Viasco, David Lapota, Ronika Alexander, Judy Ho, Maureen Mayes, Kamal K. Mubarak, Steve Schabel, Richard M. Silver, Robert W. Simms, Michael Roth, Charlie Strange, Amanda Mondt, J H Korn, Wen Ling Joanie Chung, Vivien Hsu, Laura K. Hummers, Richard I. Silver, Mark Metersky, Fred M. Wigley, Katie Caldwell, Albert J. Polito, Tan Filemon, Sandra A. A. Oldham, Robert Elashoff, John Varga, John A. Davis, Shiva Arami, Edwin Smith, Andrew Wilbur, Dinesh Khanna, Mitchell A. Olman, Melynn Nuite, Tina Parkhill, Patricia Cole-Saffold, Peter Clarke, Robert A. Wise, Gwen Leatherman, Christine Antolos, Joseph Silva, Barri J. Fessler, Edwin A. Smith, Louis W. Heck, Marilyn Perry, Paul Wolters, Julianne E. Wilson, Lovlette Woolcock, Jerry A. Molitor, Daniel E. Furst, Richard Cobb, Steven Kirkland, Dean Schraufnagel, Judith K. Amorosa, Zora Injic, Samantha Jordan, Richard Hinke, Michael D. Roth, Charles A. Read, Richard Webb, Kari Connolly, Marie Daniel, Cirrelda Cooper, Steven Springmeyer
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 177:91-98
The presence of inflammatory cells on bronchoalveolar lavage is often used to predict disease activity and the need for therapy in systemic sclerosis-associated interstitial lung disease.To evaluate whether lavage cellularity identifies distinct subs
Publikováno v:
Advances in Pulmonary Hypertension. 7:249-254
This discussion was moderated by Karen A. Fagan, MD, Professor and Director, Division of Pulmonary Medicine, University of South Alabama College of Medicine, Mobile, Alabama. Panel members included Kamal K. Mubarak, MD, Assistant Professor of Medicin
Autor:
Robert W. Simms, Philip J. Clements, Virginia D. Steen, Charlie Strange, Robert A. Wise, Mark L. Metersky, Vivien Hsu, Fredrick M. Wigley, Naomi F. Rothfield, Marcy B. Bolster, B. J. Fessler, Dean E. Schraufnagel, Daniel E. Furst, Arthur C. Theodore, David J. Riley, Dinesh Khanna, Michael D. Roth, Charles A. Read, Kamal K. Mubarak, Richard M. Silver, Ed Parsley, James R. Seibold, M. Kari Connolly, Barbara White, Xiaohong Yan, Mitchell A. Olman, Robert Elashoff, Maureen D. Mayes, Donald P. Tashkin, Jeffrey A. Golden, John Varga
Publikováno v:
Arthritis & Rheumatism. 56:1676-1684
Objective To assess the impact of cyclophosphamide (CYC) on the health-related quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. Methods One hundred fifty-eight subjects participated in the Scleroderma Lung Study, wit
Autor:
Edgar Arriola, Arthur C. Theodore, Robert W. Simms, Charlie Strange, Philip J. Clements, Virginia D. Steen, Naomi F. Rothfield, Kamal K. Mubarak, B. J. Fessler, M. Kari Connolly, Vivien Hsu, Mark L. Metersky, Fredrick M. Wigley, Jonathan G. Goldin, Daniel E. Furst, Ed Parsley, James R. Seibold, Barbara White, John Varga, Robert A. Wise, Richard M. Silver, Michael D. Roth, Charles A. Read, Jeffrey A. Golden, Dean E. Schraufnagel, Robert Elashoff, Maureen D. Mayes, Donald P. Tashkin, Mitchell A. Olman, Marcy B. Bolster, David J. Riley
Publikováno v:
New England Journal of Medicine. 354:2655-2666
BACKGROUND We conducted a double-blind, randomized, placebo-controlled trial to determine the effects of oral cyclophosphamide on lung function and health-related symptoms in patients with evidence of active alveolitis and scleroderma-related interst
Autor:
Arthur C. Theodore, Mildred Sterz, Donald P. Tashkin, John Varga, Robert Elashoff, Dinesh Khanna, Michael D. Roth, Jerry A. Molitor, M. Kari Connolly, Fredrick M. Wigley, Philip J. Clements, Virginia D. Steen, B. J. Fessler, James R. Seibold, Yun Chon, Kamal K. Mubarak, Richard M. Silver, John FitzGerald, Joannie Chung, Daniel E. Furst, Naomi F. Rothfield, Maureen D. Mayes
Publikováno v:
Arthritis & Rheumatism. 52:592-600
Objective To determine whether baseline self-assessment measures of health status and physiologic indices of disease severity in alveolitis-positive patients with systemic sclerosis (SSc) correlate with the severity of their dyspnea, and to quantify
Autor:
Gregory J. Kato, David B. Badesch, Namita Sood, Lakshmanan Krishnamurti, Claudia R. Morris, Kenneth I. Ataga, Marilyn J. Telen, Martin H. Steinberg, Mark T. Gladwin, Victor R. Gordeuk, Oswaldo Castro, Lewis L. Hsu, Kamal K. Mubarak, Erika B. Rosenzweig, J. Simon R. Gibbs, Roberto F. Machado, Robyn J. Barst, Elizabeth S. Klings, Laura DeCastro, Kevin C. Wilson
Background: In adults with sickle cell disease (SCD), an increased tricuspid regurgitant velocity (TRV) measured by Doppler echocardiography, an increased serum N-terminal pro–brain natriuretic peptide (NT-pro-BNP) level, and pulmonary hypertension
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f83b290babaa12232c45796df42896b
https://europepmc.org/articles/PMC3983842/
https://europepmc.org/articles/PMC3983842/